Quadlytics is a Kyoto-based digital-health medical-device startup founded in 2018 as a Kyoto University and Kumamoto University venture. It develops a non-invasive epilepsy seizure-warning system (tentative name: epilepsy alarm) that monitors autonomic nervous-system changes via heart-rate variability from a wearable ECG sensor and applies machine-learning anomaly detection to alert patients minutes before a seizure. Clinical development spans Japan and Australia, where subsidiary Quadlytics Pty Ltd, established in 2024 after joining MedTech Actuator Cohort 9, targets a 2028 Australian launch with research partners Monash University and Alfred Hospital, followed by UK, EU and US market entry through JETRO J-StarX programs and a Mayo Clinic Platform collaboration.
1
Round
1
Industry
5
Tags
Nov 4, 2026
Latest raise
Funding activity · 1 round
Nov 4, 2026
JPY 600M
Series B
Led by Kanpo NEXT Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
